Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Avidity Biosciences Inc
RNACurrent price
40.46 USD
-0.31 USD (-0.76%)
Last closed
40.76 USD
Company
www.aviditybiosciences.com
ISIN
US05370A1088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
5 201 635 840 USD
Yield for 12 month
+494.13 %
1Y
3Y
5Y
10Y
15Y
RNA
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California. Address: 10578 Science Center Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
66.8 USDP/E ratio
–Dividend Yield
–Current Year
+9 560 000 USD
Last Year
+9 224 000 USD
Current Quarter
+2 045 000 USD
Last Quarter
+3 543 000 USD
Current Year
+7 459 000 USD
Last Year
+9 224 000 USD
Current Quarter
+1 358 000 USD
Last Quarter
+2 902 000 USD
Key Figures RNA
1 year
3 years
5 years
10 years
EBITDA
-282 672 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-18.2 %
PEG Ratio
–
Return On Equity TTM
-28.36 %
Wall Street Target Price
66.8 USD
Revenue TTM
10 599 000 USD
Book Value
11.18 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-11.7 %
Dividend Yield
–
Gross Profit TTM
-141 180 000 USD
Earnings per share
-2.95 USD
Diluted Eps TTM
-2.95 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics RNA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RNA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation RNA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
368.3269
Price Sales TTM
490.7667
Enterprise Value EBITDA
-5.7172
Price Book MRQ
4.2542
Financials RNA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RNA
For 52 weeks
4.83 USD
48.8 USD
50 Day MA
43.29 USD
Shares Short Prior Month
12 952 998
200 Day MA
24.68 USD
Short Ratio
9.95
Shares Short
12 918 389
Short Percent
14.81 %
BeatStart